Ciprandi G - Search Results

1

Characteristics of patients with allergic polysensitization: the POLISMAIL study.

Ciprandi G, Alesina R, Ariano R, Aurnia P, Borrelli P, Cadario G, Capristo A, Carosso A, Casino G, Castiglioni G, Cesinaro Di Rocco P, Colangelolo C, Di Gioacchino M, Di Paola MG, Errico G, Fiorina A, Gambuzza F, Gangemi S, Gasparini A, Giugno R, Iemoli E, Isola S, Maniero G, Marengo F, Mazzali P, Minelli M, Mosca M, Pellegrino R, Piconi S, Pravettoni V, Quaglio L, Ricciardi L, Ridolo E, Sillano V, Valle C, Varin E, Verini M, Zambito M, Riario-Sforza GG, Incorvaia C, Puccinelli P, Scurati S, Frati F. Ciprandi G, et al. Eur Ann Allergy Clin Immunol. 2008 Nov;40(3):77-83. Eur Ann Allergy Clin Immunol. 2008. PMID: 19334371

2

Protective effect of different doses of terfenadine on the conjunctival provocation test.

Ciprandi G, Buscaglia S, Iudice A, Canonica GW. Ciprandi G, et al. Allergy. 1992 Aug;47(4 Pt 1):309-12. doi: 10.1111/j.1398-9995.1992.tb02059.x. Allergy. 1992. PMID: 1443450 Clinical Trial.

3

Non-steroidal treatment of pollen-induced conjunctivitis: comparison of different pharmacological protocols.

Ciprandi G, Cerqueti PM, Sacca S, Ciurlo G, Tosca MA, Canonica GW. Ciprandi G, et al. Allergy. 1991 Jul;46(5):393-5. doi: 10.1111/j.1398-9995.1991.tb00604.x. Allergy. 1991. PMID: 1928663 Clinical Trial.

4

Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis.

Ciprandi G, Cerqueti PM, Sacca S, Cilli P, Canonica GW. Ciprandi G, et al. Ann Allergy. 1990 Aug;65(2):156-8. Ann Allergy. 1990. PMID: 1974402 Clinical Trial.

5

Incidence of digestive diseases in patients with adverse reactions to foods.

Ciprandi G, Canonica GW. Ciprandi G, et al. Ann Allergy. 1988 Nov;61(5):334-6. Ann Allergy. 1988. PMID: 3189958

6

Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge.

Ciprandi G, Buscaglia S, Pesce G, Passalacqua G, Rihoux JP, Bagnasco M, Canonica GW. Ciprandi G, et al. J Allergy Clin Immunol. 1995 Feb;95(2):612-21. doi: 10.1016/s0091-6749(95)70324-1. J Allergy Clin Immunol. 1995. PMID: 7531732 Clinical Trial.

7

Loratadine in the treatment of cough associated with allergic rhinoconjunctivitis.

Ciprandi G, Buscaglia S, Catrullo A, Marchesi E, Bianchi B, Canonica GW. Ciprandi G, et al. Ann Allergy Asthma Immunol. 1995 Aug;75(2):115-20. Ann Allergy Asthma Immunol. 1995. PMID: 7648374 Clinical Trial.

8

Deflazacort protects against late-phase but not early-phase reactions induced by the allergen-specific conjunctival provocation test.

Ciprandi G, Buscaglia S, Pesce GP, Iudice A, Bagnasco M, Canonica GW. Ciprandi G, et al. Allergy. 1993 Aug;48(6):421-30. doi: 10.1111/j.1398-9995.1993.tb00740.x. Allergy. 1993. PMID: 7902021 Clinical Trial.

9

Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure.

Ciprandi G, Pronzato C, Ricca V, Bagnasco M, Canonica GW. Ciprandi G, et al. J Allergy Clin Immunol. 1994 Oct;94(4):738-46. doi: 10.1016/0091-6749(94)90182-1. J Allergy Clin Immunol. 1994. PMID: 7930308

10

Allergen-specific conjunctival challenge in children with allergic asthma: a clinical tool.

Ciprandi G, Tosca MA, Fasce L, Canonica GW. Ciprandi G, et al. Allergy. 1994 Jul;49(6):489-91. doi: 10.1111/j.1398-9995.1994.tb00847.x. Allergy. 1994. PMID: 8074273 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

936 results

Search Page

Filters